BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CURE GABA-A - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://curegabaa.org
X-WR-CALDESC:Events for CURE GABA-A
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240312T110000
DTEND;TZID=America/Los_Angeles:20240312T120000
DTSTAMP:20260419T084044
CREATED:20240127T054411Z
LAST-MODIFIED:20240311T195920Z
UID:2059-1710241200-1710244800@curegabaa.org
SUMMARY:Cure GABA-A | Understanding the benefits of a Natural History Study
DESCRIPTION:Join us for an engaging online session where we’ll explore the advantages of a Natural Historical Study\n\n\nCure GABA-A | Educational Session with Q&A | Understanding the benefits to patients of a Natural History Study \nEvent Description: Join us for an informative online session on GABA-A\, where we will delve into the benefits a Natural History Study offers to patients. Our expert Dr. Rikke Steensbjerre Møller will provide insights on the natural history of GABA-A and how it can be a game-changer in patient care.  \nGet ready to have your questions answered during the interactive Q&A session.  \nDr. Rikke Steensbjerre Moller leads the dedicated team at the Danish Epilepsy Centre\, the primary focus is enhancing the diagnosis process for individuals with severe genetic epilepsy through advanced genetic testing. \nCommitted to fostering awareness about genetic epilepsies\, they recognize the profound impact of natural history in genetic epilepsies. \nDr. Moller and her team strive to deepen their understanding of the correlations between genetic factors and clinical symptoms\, all while actively seeking out innovative treatment options. \n \nCure GABA-A has invited all of our friends to join an educational session with Dr. Rikke Steensbjerre Møller January 29th\, 2023 10am PDT. For more details contact us on our socials or email: monica@cureGABAa.com\n \nCan’t make it in person? Don’t worry –This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nwww.youtube.com/@CureGABAa \n \nJoin Cure GABA-A in this collective mission to improve the lives of patients with GABA-A Variants work toward a brighter future.
URL:https://curegabaa.org/event/cure-gaba-a-understanding-the-benefits-of-a-natural-history-study/
ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/ccd8217ce4c48a656e83e476b8e181a6.jpg
ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240322T100000
DTEND;TZID=America/Los_Angeles:20240322T110000
DTSTAMP:20260419T084044
CREATED:20240321T025902Z
LAST-MODIFIED:20240322T025934Z
UID:2815-1711101600-1711105200@curegabaa.org
SUMMARY:Cure GABA-A | Understanding GABA-A and its Relationship to Epilepsy
DESCRIPTION:Dr. Michael Rogawski\, from UC Davis Health\, will help us understand GABA-A and its relationship to epilepsy\n\n\nJoin us for an educational session with Dr. Michael Rogawski. \nDr. Michael Rogawski\, a professor and physician at UC Davis Health\, will help us understand GABA-A and its relationship to Epilepsy. \nDr. Rogawski has been elected a fellow of the National Academy of Inventors (NAI)\, the highest professional distinction for academic inventors. His inventions in drug discovery and development\, particularly in the field of neuropharmacology\, have led to significant advancements in treating epilepsy and neuropsychiatric conditions. \nDr. Rogawski’s election as an NAI fellow recognizes his prolific spirit of innovation and contributions to improving the quality of life through groundbreaking inventions. Notable achievements include the development of epilepsy drug perampanel (Fycompa®) and brexanolone (Zulresso™)\, the first FDA-approved drug for postpartum depression. His work reflects a dedication to translational research and collaboration within the scientific community. \nJoin Cure GABA-A and Dr. Michael Rogawski on March 22\, 2024 10:00 AM PDT for an educational session. For more details\, contact us on our socials or email: monica@cureGABAa.com. \nCan’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our collective mission to improve the lives of patients with GABA-A Variants and work toward a brighter future.
URL:https://curegabaa.org/event/cure-gaba-a-understanding-gaba-a-and-its-relationship-to-epilepsy/
ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/03/9ea401c2d4d67dc4f2f23103cd8b4a5d-1.jpg
ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org
END:VEVENT
END:VCALENDAR